Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The study is conducted in Europe. The primary aim of this observational study is to compare
the insulin sensitivity in small for gestational age (SGA) subjects treated with Norditropin®
with untreated small for gestational age (SGA) subjects and with average for gestational age
(AGA) subjects.